FDA Approved: ONFI — Supplemental Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

The FDA has approved a supplemental application for ONFI (clobazam) submitted by Lundbeck Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• ONFI (clobazam)

Snippet

SUPPL AP for ONFI (CLOBAZAM)